L-Carnitine for Wound Healing in People With Diabetic Foot Ulcer
Tests L-carnitine supplements on ulcer size in people with diabetic foot ulcer.
Key facts
- Who runs it
- Ain Shams University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- The Effect of L-Carnitine on Wound Healing in Patients With Diabetic Foot Ulcer.
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 50 people, planned
- Started
- 1 Sept 2026
- Expected to end
- 1 Aug 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- L- carnitine
- Record updated
- 17 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with diabetes, nerve damage from diabetes and a mild to moderate diabetic foot ulcer. It tests L-Carnitine added to standard care.
- Age
- 30 to 75 years
- Sex
- Men and women
- Disease stage
- Diabetic foot ulcer grade 1-2 (mild to moderate) on the Wagner scale, with diabetic neuropathy (nerve damage). Diabetes for 5 - 10 years.
- Earlier treatment
- People must take a stable dose of diabetes medicine before and during the study. No antioxidant supplements (vitamin E, ascorbic acid, omega 3 fatty acid, Coenzyme Q10) in the three months before joining.
- Biomarker or test result
- HbA1c (a blood test of long-term sugar levels) < 9.
Main reasons for not taking part
- Ulcers from other causes
- Autoimmune disease
- Liver disease or kidney disease
- Taking medicines for cancer
- Thyroid disease
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Adult Male or Female patients with diabetic neuropathy mean age (30-75) years old
- Having Diabetic neuropathy and Diabetic foot ulcer grade 1-2 (mild- moderate) according to Wagner classification
- Uncontrolled diabetic patients (HbA1c). < 9 duration of diabetic (5 - 10) years
- All patient treated with stable dose of anti-diabetic medication priors and during the period of the study
Who cannot take part
- Patient taking any antioxidant supplements including vitamin E, ascorbic acid, omega 3 fatty acid, Coenzyme Q10 within three months prior to enrollment in the study
- Patient with autoimmune disease
- Patient with liver disease or kidney disease
- Patient taking medications for cancer
- Patient with thyroid disease
- Patients with other causes of ulcers
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 75 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Primary outcome: To evaluate the efficacy of L-Carnitine supplementation on length and depth ulcer size
Read full original descriptionShow less
Secondary outcome: To investigate the effect of L-Carnitine supplements on:
1. Vascular endothelial growth factor (VEGF) 2. Inflammatory markers TNF-a (Tumor necrosis factor alpha). 3. Hemoglobin A1C (HbA1c) And Lipid profile (cholesterol, triglycerides, high-density Lipoprotein (HDL) and low-density lipoprotein (LDL)). 4. To assess the type and likelihood of any adverse drug reaction that can be related to L-Carnitine supplementation. 5. QOL (DIABETES 39)
The 2 groups in the trial
- TreatmentTreatment being tested
To receive oral L-carnitine plus standard care therapy
Treatment: L- carnitine
- ControlNo study treatment, for comparison
To receive only standard of care therapy
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effect of L-Carnitine on Wound Healing in Patients With Diabetic Foot Ulcer.
- Plain-language title
- L-Carnitine for Wound Healing in People With Diabetic Foot UlcerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT07768228, who can take part
- Record updated
- 17 August 2026